Trials / Completed
CompletedNCT02650141
Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
Efficacy of Experienced Chinese Herbal Formulas for the Treatment of Different Types of Precocious Puberty: A Single-blinded Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 143 (actual)
- Sponsor
- Children's Hospital of Fudan University · Academic / Other
- Sex
- Female
- Age
- 8 Years
- Healthy volunteers
- Not accepted
Summary
Due to various complex factors, the incidence of precocious puberty is increasing rapidly. It severely threatens physical and mental health of children. It's urgent to explore effective ways to control the disease.
Detailed description
In the research, 138 precocious puberty children are randomly divided into the Ziyinxiehuo granules group (69 cases) and Zishenqinggan granules group(69 cases). Patients in Ziyinxiehuo granules group are treated with a series of experienced chinese herbal formulas, whereas the Zishenqinggan granules group received with different series of experienced chinese herbal formulas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ziyinxiehuo Granules | Ziyinxiehuo granules Herbs (1 bag ): shengdi 5g, xuanshen 3g, zexie 3g, zhimu3g, huangpai 3g, zhiguiban 2g, maiya 6g,tiandong 3g, zhigancao 2g Therapeutic Principle: Nourishing "Yin", removing "Fire" Usage: administered after dissolved, 3 times per day after breakfast and supper |
| DRUG | zishenqinggan Granules | Zishenqinggan granules Herbs (1 bag ): Shengdi 5g, baishao 3g, huangqin 3g, fuling 4g, danpi 3g, maiya 6g, shanzha 3g, zhebei 3g, zhigancao 2g Therapeutic Principle: replenishing "Kidney", Clearing "Liver" Usage: administered after dissolved, 3 times per day after breakfast and supper |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2015-11-01
- Completion
- 2016-04-01
- First posted
- 2016-01-08
- Last updated
- 2019-12-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02650141. Inclusion in this directory is not an endorsement.